| Trial ID: | L0098 |
| Source ID: | NCT00650546
|
| Associated Drug: |
Exenatide
|
| Title: |
Role of Exenatide in NASH-a Pilot Study
|
| Acronym: |
NAFLD
|
| Status: |
Completed
|
| Study Results: |
Has Results
|
| Results: |
https://ClinicalTrials.gov/show/NCT00650546/results
|
| Conditions: |
Nonalcoholic Fatty Liver Disease
|
| Interventions: |
Drug: Exenatide
|
| Outcome Measures: |
Number of Patients With Improvement in Liver Histology After Treatment With Exenatide|Change in NAS
|
| Sponsor/Collaborators: |
Indiana University|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
|
| Gender: |
All
|
| Age: |
18 Years to 99 Years ?? (Adult, Older Adult)
|
| Phases: |
Phase 2/Phase 3
|
| Enrollment: |
8
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other
|
| Start Date: |
August 2006
|
| Completion Date: |
August 2010
|
| Results First Posted: |
May 12, 2016
|
| Last Update Posted: |
April 11, 2017
|
| Locations: |
Indiana University, Indianapolis, Indiana, United States|Kansas City VA Medical Center, Kansas City, Missouri, United States|Fort Sam Houston, San Antonio, Texas, United States
|
| URL: |
https://ClinicalTrials.gov/show/NCT00650546
|
